Skip to content
2000
Volume 20, Issue 14
  • ISSN: 1385-2728
  • E-ISSN: 1875-5348

Abstract

Disulfide bond plays an important role in various fields, for example, biochemical processes, industrial and pharmaceutical chemistry, bioconjugates, peptidomimetics and selfassembled monolayers (SAMs) etc. In the past decades, drug delivery systems (DDS) have been widely investigated, and disulfide-based oxidation-reduction responsive DDS is the most promising one. Disulfide bonds have no physiological toxicity and remain stable in human body, and can be broken into a reduced form of glutathione (GSH) via the thiol-disulfide exchange reaction. Moreover, the GSH level in tumor tissues has been known to be at least 4-fold higher than that in normal tissues. Therefore, this specific redox potential in cells stimulates people to design oxidation-reduction responsive DDS for specifically releasing drugs in tumor cells and develop the new methods for the preparation of organic disulfanes. The present review has attempted to comprehensively summarize recent advances on the synthetic methods of disulfide bond in drug delivery systems.

Loading

Article metrics loading...

/content/journals/coc/10.2174/1385272820666151207194002
2016-06-01
2025-05-19
Loading full text...

Full text loading...

/content/journals/coc/10.2174/1385272820666151207194002
Loading

  • Article Type:
    Research Article
Keyword(s): carrier; Disulfane synthesis; disulfide bonds; drug delivery systems; prodrug
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test